Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
84,800
+1,800 (2.17%)
At close: Dec 5, 2025
Mezzion Pharma Revenue
Mezzion Pharma had revenue of 2.13B KRW in the quarter ending September 30, 2025, a decrease of -5.89%. This brings the company's revenue in the last twelve months to 7.75B, down -44.95% year-over-year. In the year 2024, Mezzion Pharma had annual revenue of 8.61B, down -72.85%.
Revenue (ttm)
7.75B
Revenue Growth
-44.95%
P/S Ratio
332.26
Revenue / Employee
430.53M
Employees
18
Market Cap
2,574.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.61B | -23.11B | -72.85% |
| Dec 31, 2023 | 31.72B | 994.76M | 3.24% |
| Dec 31, 2022 | 30.73B | 4.07B | 15.28% |
| Dec 31, 2021 | 26.65B | -1.98B | -6.92% |
| Dec 31, 2020 | 28.63B | 10.71B | 59.79% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Samsung Biologics | 5,504.84B |
| Hyundai Motor Company | 186.04T |
| Doosan Enerbility | 16.79T |
| KB Financial Group | 14.89T |
| HD Hyundai Heavy Industries | 16.39T |